Welcome to our dedicated page for Aramark SEC filings (Ticker: ARMK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Aramark (ARMK) filings document a Delaware operating company with NYSE-listed common stock and a business centered on food, facilities management, hospitality, and support services. Its 8-K reports include operating results, material definitive agreements, annual meeting voting results, and compensation matters involving restricted stock units and executive equity awards.
Proxy materials disclose board elections, auditor ratification, executive compensation, equity awards, shareholder voting matters, and governance practices. Financing filings also describe amendments to the credit agreement of Aramark Services, Inc., an indirect wholly owned subsidiary, including term-loan refinancing and repricing transactions within the company’s capital structure.
Aramark (ARMK) director Bridgette P. Heller reported an automatic acquisition of 75.532 shares of common stock-equivalent rights on September 9, 2026. These represent dividend equivalent rights credited on deferred stock units in connection with Aramark’s quarterly dividend and vest on the same schedule as the underlying awards, bringing her directly held total to 35,896.827 shares.
Aramark (ARMK) director Kenneth M. Keverian reported an automatic acquisition of 61.449 dividend equivalent rights on September 9, 2026, tied to the company’s quarterly dividend on deferred stock units. These rights were granted at $0.00 per right and increase his directly held common stock-equivalent position to 29,203.826 shares. The dividend equivalent rights vest on the same schedule as the underlying deferred stock unit awards, and no Rule 10b5-1 trading plan is reported.
Aramark (symbol: ARMK) is the issuer of record for a Form 4 filing submitted to the SEC. King Karen Marie reported acquisition or exercise transactions in this Form 4 filing.
Aramark (ARMK) reported that director Karen Marie King received an award of 24.471 shares of Common Stock equivalents on September 9, 2026. These represent dividend equivalent rights that accrued on her deferred stock units in connection with Aramark’s quarterly dividend and vest on the same schedules as the underlying awards. Following this award, she holds 42,827.279 common-share equivalents directly. No Rule 10b5-1 trading plan is reported for this transaction.
Aramark (ARMK) director Patricia E. Lopez reported an automatic acquisition of 61.449 shares of common stock-equivalent units on September 9, 2026. These represent dividend equivalent rights credited on her deferred stock units in connection with Aramark’s quarterly dividend, bringing her directly held total to 29,203.826 shares.
Aramark (symbol: ARMK) is the issuer of record for a Form 4 filing submitted to the SEC. SADOVE STEPHEN I reported acquisition or exercise transactions in this Form 4 filing.
Aramark (ARMK) director Stephen I. Sadove reported an automatic grant of 187.656 common-share equivalents on September 9, 2026, described as dividend equivalent rights that accrued on his deferred stock units in connection with Aramark’s quarterly dividend. The rights were received at no cash price and vest on the same schedule as the underlying awards, bringing his directly held common stock (including deferred units) to 102,694.423 shares. He also reports 15,000 shares held indirectly by a trust. No Rule 10b5-1 trading plan is reported for these holdings.
Aramark (ARMK) reported that director Kevin Wills acquired additional common stock-related rights on September 9, 2026 through a grant classified as a grant, award, or other acquisition tied to existing deferred stock units. The filing states this represents 34.551 dividend equivalent rights accruing from the company’s quarterly dividend, bringing his directly held common stock-related position to 21,974.546 shares after the transaction. These dividend equivalent rights vest on the same schedule as the underlying deferred stock unit awards, and no Rule 10b5-1 trading plan is reported.
Aramark (ARMK) reports that EVP and CFO James J. Tarangelo exercised stock options for 8,852 shares of Common Stock on September 3, 2026 at an exercise price of $24.58 per share. In connection with this fully vested option, 6,048 shares of Common Stock were delivered or withheld to satisfy the payment of the exercise price and tax withholding obligations. These options were scheduled to expire on November 18, 2026, and no Rule 10b5-1 trading plan is reported.
Aramark COO, U.S. Food & Facilities Marc A. Bruno reported a series of option exercises and related share dispositions on August 13, 2026. He exercised 210,402 stock options into an equal number of Aramark common shares at exercise prices of $24.58, $29.38, and $26.50 per share on fully vested options that were scheduled to expire between November 2026 and November 2028.
To cover the option exercise price and tax withholding obligations, 139,768 shares of common stock were withheld by Aramark. In addition, Bruno sold 55,245 shares at a weighted average price of $60.92 per share (in trades ranging from $60.35 to $61.34) and 15,389 shares at a weighted average price of $61.42 per share (ranging from $61.35 to $61.50). Overall, the transactions combine option exercises, shares withheld for costs, and open-market sales.
Aramark filed an initial statement of beneficial ownership identifying Antony Spring as a director. The filing reports no non-derivative or derivative holdings and no transactions. It also includes an Exhibit 24 Power of Attorney authorizing certain actions on the reporting person’s behalf.